ENO1-mediated deoxycytidine synthesis and gemcitabine resistance by stabilizing RRM2 in pancreatic cancer

Yongning Li, Hao Wang, Liwen Chen, Yanyu Gong, Dijie Zheng, Futang Li, Changhao Wu, Zhiwei He, Chao Yu · 2025

Read ENO1-mediated deoxycytidine synthesis and gemcitabine resistance by stabilizing RRM2 in pancreatic cancer by Yongning Li, Hao Wang, Liwen Chen, Yanyu Gong, Dijie Zheng, Futang Li, Changhao Wu, Zhiwei He, Chao Yu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12847938.txt.

Description

Yongning Li and eight co-authors trace in 2025 why pancreatic cancer often shrugs off a key drug. The drug, gemcitabine, fails when cancer cells boost their supply of DNA building blocks. One protein that makes those blocks, RRM2, runs high in many cancers.

High levels of a second protein, ENO1, track with drug failure in patients. Cell and animal tests show ENO1 shields RRM2 from a tag that would mark it for breakdown. With more RRM2 kept intact, cells make more blocks and resist the drug. The chain points to ENO1 as a target that could restore drug response, a fresh angle for a cancer with few good options.

Catalog record

CREATORYongning Li, Hao Wang, Liwen Chen, Yanyu Gong, Dijie Zheng, Futang Li, Changhao Wu, Zhiwei He, Chao Yu
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12847938

Browse the full library · About the Tower of Babel